Global Polyps Market 2020 Analysis By Manufacturers, Latest Trends, Competitive Landscape And Strategies

 Global Polyps Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

The Global Polyps Market is expected to reach US$ 18.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 9.2 % during the forecast period 2017-2023. Polyps Market information: by stage (benign, pre-malignant) by types (digestive polyps, endometrial polyp, and others) by diagnosis (occult blood and stool test, colonoscopy, and others) by treatment (drugs and surgery) by end users- Global forecast till 2023  

Competitive Landscape

The intense polyps market is experiencing several tactical moves implemented by major market influencers. Strategies would include mergers, acquisitions, collaborations, and other methods. For instance, Medtronic is planning to acquire Smith & Nephew’s gynecology business as a part of their endeavor to make their procedures less invasive.

Also Read : https://www.medgadget.com/2019/07/polyps-market-2019-seeking-growth-from-emerging-trends-by-registering-9-2-cagr-by-2023-cook-medical-endo-pharmaceuticals-inc-pfizer-inc-novartis-ag-millennium-surgical-corp-etc.html 

Key players profiled in the report are Medtronic, B. Braun Melsungen AG, Cook Medical, Endo Pharmaceuticals Inc., Pfizer Inc., Novartis AG, Millennium Surgical Corp., Black Smith Surgical, Teva Pharmaceutical Industries Ltd., Mylan Inc., Sun Pharmaceuticals and others.

Market Drivers

Mucus membrane’s abnormal growth is known as a polyp. It is most commonly found in colon, stomach, nose, ear, sinus, urinary bladder, uterus, and other parts where mucus membrane exists. Mostly non-cancerous, the polyp can turn into a cancerous cell with allowed growth. The risk of getting cancer goes higher with growth. But what makes it truly problematic is its tendency to avoid detection. Timely screening can only help in detecting symptoms. The global polyps market can experience a robust 9.2% CAGR during the forecast period (2017-2023) to reach an astonishing USD 18.3 billion market valuation, claims Market Research Future (MRFR) in a report that has its focus on in-depth segmental analysis and chief driving factors. Rising geriatric population, growth in screening due to increasing awareness regarding polyp can have a definitive impact on the polyps market.

On the flip side, polyp surgery has its risk such as excessive bleeding and infection during surgery which leads many towards minimally invasive surgeries. But this often incurs more cost. Furthermore, cost is always a concern in developing countries which could bog down the polyps market. Polyp recognition is also necessary. As it remains mostly dormant, it can hold back the expected polyps market growth.

Industry Trend

Intersect ENT’s Sinuva is a sinus implant that can work wonder for patients who have already undergone ethmoid sinus surgery. Upon placement, this would release anti-inflammatory steroid directly to the diseased site for a maximum of 90 days’ time span. This implant can reduce the chances of having a repeat surgery.

Researchers from HudsonAlpha Institute for Biotechnology have found a measurable indicator in blood plasma which could identify patients with colon polyps. In the process, it could end use of certain colonoscopies that were previously irreplaceable in determining polyps.

Segments

The global polyps market can be segmented on the basis of stage, types, diagnosis, surgery and end users.

Stage-wise, the polyps market includes benign and pre-malignant.

Based on types, the polyps market can be segmented into digestive polyps, endometrial polyp, cervical polyp, nasal polyps, laryngeal polyps and pre-malignant.

Diagnosis-based segmentation of the polyps market includes occult blood & stool test, colonoscopy, sigmoidoscopy, double contrast barium enema, computed tomography, and others.

Based on treatment, the polyps market comprises drugs and surgery. Drugs can be further segmented into hormonal drugs, painkillers and others and surgery can be sub-segmented into polypectomy, minimally invasive surgery, colon and rectum removal, and others.

Based on the end-users, the polyps market includes hospitals & clinics, academic and research, and others.

Regional Analysis

Geographical analysis of the polyps market includes regions namely the Americas, Europe, Asia Pacific (APAC), and the Middle East & the Africa (MEA).

The Americas are the market frontrunners. With a substantial amount of revenue, the Americas is dominating the global polyps market. This superiority can be attributed to its premium healthcare infrastructure and implementation of world-class technology, along with significant healthcare investment.

Europe is doing great by increasing its expenditure on government funding for research and development. Healthcare market has penetrated well in Europe, and high disposable income is giving the sector much to cheer. The segment has proliferated well and is founding further success on gains made by the healthcare sector.

The APAC, with a revamped healthcare sector, is showing much promises for further growth. The regional market is galloping fast on the industrial success of emerging economies such as China and India.

The MEA market can bank on the U.A.E. and Saudi Arabia’s infrastructural superiority. However, the African region can stumble a lot due to the presence of several poor economies in the region.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/polyps-market-4176 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

World Nutrigenomics Market Top Key Players Shares, Revenue, Analysis And Forecasts To 2023

 The exclusive research report on the Global Nutrigenomics Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

The Global Nutrigenomics Market is expected to grow at a 16.8% CAGR over the forecast period from 2018 to 2023, according to a new report from Market Research Future (MRFR). The Global Nutrigenomics Market is mainly driven by the growing understanding of the role of dietary choices in the outbreak of diseases and the various ways in which the dietary pattern can be altered to act as a solution to certain diseases.

The Global Nutrigenomics Market is expected to rise to a value of USD 17,313.5 million by the end of the forecast period in 2023, according to MRFR.

Also Read : https://www.medgadget.com/2019/04/nutrigenomics-market-2019-global-overview-by-size-share-growth-demand-upcoming-techniques-trends-and-industry-analysis-by-2023.html 

The Global Nutrigenomics Market is driven by the growing awareness about the diet’s importance in maintaining one’s health and avoiding or managing diseases. As the global population has become more fitness-conscious, the interest in the role of dietary choices in the overall health of the individual has grown. Increasing interest in holistic lifestyles has also led to an increasing interest in the relationship between an individual’s diet and health. This has driven product development and innovation in the nutrigenomics sector and is likely to remain a key driver for the market over the forecast period.

The growing prevalence of diabetes and obesity is likely to a major driver for the global nutrigenomics market. The inherent connection between the individual’s diet and contracting diabetes or becoming obese has driven medical research as well as consumer interest in the field of nutrigenomics in recent years. Growing understanding of the intricate ways in which dietary patterns can affect the outcome and prognosis of diseases such as diabetes is likely to be a major driver for the global nutrigenomics market over the forecast period. The growing prevalence of obesity is also likely to be a major driver for the global nutrigenomics market over the forecast period, as altering the dietary patterns to fulfill the individual’s hunger while reducing the caloric load of meals has become popular as a method of combating obesity.

Competitive Dashboard

Leading players in the global nutrigenomics market include WellGen Inc., Genomix Nutrition Inc., NutraGene, Cura Integrative Medicine, XCODE Life Sciences Pvt. Ltd., Nutrigenomix, and Metagenics Inc.

 Industry Updates:

In February 2019, a study conducted by researchers at King’s College London found that the anthocyanins responsible for giving blueberries their blue color may also be responsible for the heart-healthy benefits of the fruit. The study was conducted with nutrigenomic techniques and is among the many happenings in the global nutrigenomics market at present.

In Nov 2018 a top digital health and genetic testing company named Prenetics had announced the launch of Circle. This is a consumer DNA testing platform which provides nutrigenomics tests along with cancer DNA test.

Segments for Global Nutrigenomics Market

The global nutrigenomics market is segmented on the basis of product, technique, application, and region.

By product, the global nutrigenomics market is segmented into reagents & kits and services.

By technique, the global nutrigenomics market is segmented into saliva, blood, buccal swab, and others.

By application, the global nutrigenomics market is segmented into obesity, diabetes, chronic diseases, and anti-aging products. Obesity is the clear leader in the global nutrigenomics market by application, as the segment holds a dominant share of around 70% in the market and is likely to grow at a steady rate over the forecast period due to the growing prevalence of obesity. The diabetes segment is also likely to be a prosperous avenue for the nutrigenomics market over the forecast period, with the segment expected to exhibit a CAGR of 17.1%.

Regional Analysis for Global Nutrigenomics Market

The global nutrigenomics market is dominated by the Americas segment, driven by the growing medical research in the field of nutrigenomics in countries such as the U.S. and Canada and the increasing consumer interest in improved and enhanced food products. The Americas segment is expected to reach a valuation of USD 6,316.4 million by the end of the forecast period in 2023.

Europe is also a major regional player in the market and is likely to grow at a solid 17% CAGR over the forecast period due to the increasing support for food innovations in the region. Asia Pacific is also likely to exhibit solid growth over the forecast period, with the region expected to grow at a CAGR of 17.1% over the forecast period.

The Asia Pacific region is estimated to expand at a rapid pace during the appraisal period due to the rising awareness of health and treatments, demand for holistic treatment, and increased expenditure on healthcare.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/nutrigenomics-market-4009

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Foley catheters Market Cagr Growth Expected To Be Linear To The Skyrocketing Rise ! Predicted By 2023

 Market Research Future adds the “Foley catheters Market Research Report - Forecast to 2023” report to their unique collection.

Market Research Future (MRFR) postulates that the global Foley catheters market is predicted to garner USD 987.3million, grabbing a CAGR of 7.8% during the forecast period (2018-2023).

The medical devices are evolving as healthcare facilities get more competent to ensure high service delivery. Market reports linked with the healthcare industry have been presented by Market Research Future which produces reports on other business verticals that summaries the present market scenarios.

Also Read : https://www.medgadget.com/2019/03/foley-catheters-market-987-3-million-revenue-expected-to-reach-by-top-key-manufacturers-till-2023-by-cook-teleflex-medline-industries-medtronic-etc.html 

The rise in research investments is increasing the overall product quality substantially. Factors such as the growing prevalence of urologic diseases, hospitalization, and new product development and launches is improving the overall development of the foley catheters market. Rising rates of hospitalization are expected to incentivize the market growth for foley catheters further.

Key Players :

• Braun Melsungen AG (Germany),
• Coloplast Ltd (Denmark),
• Cook (US),
• Teleflex (US),
• Medline Industries, Inc. (US), and
• Medtronic (Republic of Ireland),
• C. R. Bard, Inc. (U.S.)

are some of the leading players at the cutting edge of the competition in the market of foley catheters drug, globally.

Industry Updates :

Nov 2018 An inventor from Miami, Fla., has developed a system for preventing contamination of a foley catheter during insertion. The BIBI line and catheter feeder has a soft tip that holds the sterile catheter securely and does not leave a dent on the tip of the catheter. It nulls all acquired bloodstream infections and urinary tract infections.

In March 2018, Spinal Singularity had launched a feasibility trial of its Connected Catheter. It is a smart catheter designed especially for male patients suffering from neurogenic lower urinary tract dysfunction or chronic urinary retention.

Segments :

The Global Foley Catheters Market has been segmented on the basis of material, type, and end-user.

By mode of material, the global Foley catheters market has been segmented into silicone, latex, hydrophilic polymer coated latex; silicone elastomer coated latex, polytetrafluoroethylene PTFE (Teflon) coated latex, and others.

By mode of type, the global Foley catheters market has been segmented into 3-way catheters, 2-way catheters, 4-way catheters, and others.

By mode of end-users, the global Foley catheters market has been segmented into hospitals, medical research center, and ambulatory surgery centers.

Regional Analysis :

The regional analysis of the foley catheters comprises of regions such as Asia Pacific, Middle East, Africa, Europe and North America.

The North American region is the highest contributor for foley catheters. Owing to a vast amount of money invested in R&D and progressive products development, the North American foley catheters market is progressing favorably.

The European region is the second highest region and accounts for the next major market share due to the acceptance of new and advanced technologies and products; it is anticipated to reach USD 306.1 million by 2023. Germany is controlling this market while the UK is the fastest growing Foley catheters market in the European region.

The Asia Pacific region is observing speedy growth in this market which is mostly due to the quickly growing prevalence of many urologic diseases and increasing healthcare expenditure. The Asia Pacific foley catheters market is anticipated to expand at an optimistic CAGR during the forecast period.

The Middle East & African regions are likely to have limited growth. Although, the Middle East is growing at a better pace as compared to Africa.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/foley-catheter-market-922 

Skin Graft Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Skin Graft Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

Skin Graft Market overview

Skin grafts is a medical procedure that is performed when the injured skin cannot heal itself and in extreme cases it involves the operational procedure that turns out to be quite expensive. Many physicians also use the skin from another donor that makes the procedure more expensive.

Skin grafting is also known as skin harvesting and it includes a surgical procedure in case of burns, skin infections, and other skin problems. The cosmetics sector is also growing the skin grafting market with the changing lifestyle and the latest trends that are affecting the global market in a positive manner.

Also Read : https://www.medgadget.com/2020/05/skin-graft-market-overview-2020-global-business-growth-opportunities-industry-size-share-upcoming-trends-top-leaders-regional-revenues-forecast-to-2023.html 

The global skin graft global market report showcases the increased demand for skin grafts because of the increasing cases of burn injuries and skin infections. The rise of advanced technology equipment in skin grafts, attributing to the increased investment in the research and development activity, will positively open new opportunities for the skin grafts market. All these market factors for skin graft will lead to the growth of the global market for $7.5 billion by the end of 2023, moreover the market will be projected to grow at a CAGR of 13.5% for the forecast period from 2017-2023.

Key Players of Global Skin Graft Market:

Key players profiled in the report are 

• Organogenesis Inc.
• Specmed Medical
• Stratatech Corp
• Tissue Regenix Group PLC
• Avita Medical
• Convatec Inc
• Medrotonic
• Coloplast
• B.Braun Melsungen
• zimmerbiomet
• Stratatech Corporation
• Zimmer Biomet  

Skin Graft Market segmentation

The competitive landscape of the global skin grafts market is segmented owing to the prevalence and presence of various international and national players. On the basis of the skin graft type, the global market can be split into:

• Isogeneic
• Autologous
• Allogeneic
• Prosthetic
• Xenogeneic

Based on the growth of the global skin graft market can be further segmented based on the graft thickness, such as:

• Full-thickness
• Split-thickness
• Composite graft

And based on the applications, the global market can be classified into:

• Burns
• Extensive wounds
• Extensive skin loss due to infections
• Skin cancers
• Others

And according to the segmentation done based on the equipment, the global market can classified into:

• Dermatome
• Consumables
• General surgical instruments

And lastly based on end users, the market can be segmented into:

• Academic and research
• Hospitals and clinics
• Others

Skin Graft Market Regional segmentation

The global skin graft market is geographically distributed based on the involvement of various regions for the past few years. The United States accounts for the maximum shares in the skin graft market owing to the favourable reimbursement scenarios and expenditure in the healthcare sector. The introduction of new technologies in the US is also driving the market for global skin graft.

Europe is the second largest market with the rising awareness and the increase in the disposable incomes among the population. The market of China and India is also on its full potential with the gulf nations also participating in the skin graft market.

Skin Graft Industry news

Mallinckrodt has purchased Stratatech Corporation, a regenerative medicine company, for nearly $200 million. The company has announced a merger agreement that is focused on the development of unique, proprietary skin substitute products. These developmental products are using the regenerative skin tissue and a technology platform for genetically enhanced skin tissues.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/skin-graft-market-1674

Worldwide Enteral Feeding Devices Market Ready To Set Outstanding Growth From 2020 To 2023

 Market Highlights

The global enteral feeding devices market held a market value of USD 2,302.4 million in 2017 and is projected to grow at a CAGR of 6.1% over the forecast period. Enteral feeding is the direct delivery of nutrients into the gastrointestinal tract (GIT) via a tube which is placed into the duodenum, jejunum or stomach through mouth, nose or percutaneous route. Major factors driving the market growth are globally growing geriatric population coupled with the rising burden of chronic diseases, increasing shift from parenteral to enteral nutrition, and mounting incidence of preterm births. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. In contrast, complications associated with enteral feeding devices including inadvertent dislodgement of tubes and stringent reimbursement policies are anticipated to restrain the market growth during the next five years. Mounting technological advancement in feeding pumps such as enhanced portable pump designs with reduced risk of complications and is augmenting the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7828 

Regional Analysis

The global enteral feeding devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas would command the market over the forecast period pertaining to the presence of sophisticated medical and healthcare infrastructure and market value contributors, changing lifestyle, and the rising burden of cancer, and other noncommunicable diseases (NCDs). The American Cancer Society stated that in 2018, about 9,220 new cases of colon cancer have diagnosed in the US. 

Europe would be the second-largest value contributor in the enteral feeding devices market owing to the Asia-Pacific would represent the profitable market growth during the forecast period due to growth in geriatric population, rising incidence of oral cancer, and increasing awareness about enteric feeding devices, and surging number of hospital admissions in China, India, Japan, and Australia. The World Health Organization stated that in 2018, the incidence of oral cancer was within the top three of all cancers in a few Pacific Asian countries.

The Middle East & Africa has the least share of the global enteral feeding devices market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global enteral feeding devices market has been segmented into product, age group, indication, end user, and region.

By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

On the basis of age group, the market has been divided into adults and pediatrics.

By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others.

Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs).

Key Players

Some of the spearheading players in the global enteral feeding devices market are Medtronic plc, Cook Medical, B. Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company (BD), Fresenius Kabi AG, Danone Nutricia, Nestlé, CONMED Corporation, Moog, Inc., Halyard Health, Inc., and Vygon SA.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828 

Immunoprecipitation Market Expects An Extensive Growth In Roi Till 2023

 Market Highlights

It is estimated that the global immunoprecipitation market growth is expected to hold a market value of USD 562 million and register a CAGR ~ 5.2% during the forecast period of 2018–2023. The method of precipitating a protein antigen from a solution by using an antibody that exactly binds to that particular protein is known as immunoprecipitation. This technique can be used for isolation and concentration of a particular protein from a sample that contains thousands of different proteins. A growing number of research activities in the life sciences sector and rising need to identify antigens associated with autoimmune diseases are driving the market growth. According to a report published by the British Society of Immunology in March 2016, more than 80 autoimmune diseases have been identified. Furthermore, increasing investments by governments and industries, rising biotechnology research across the globe, and growing awareness about personalized therapeutics is fueling the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7816 

However, the presence of alternative technologies for protein purification may negatively affect market growth during the forecast period.

The global immunoprecipitation market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2018, Abcam plc entered into a strategic agreement with F. Hoffmann-La Roche Ltd, a leading biotech company, under which Abcam received the exclusive rights to the product portfolio of Spring, that consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products. 

Regional Analysis

Americas is anticipated to dominate the global immunoprecipitation market owing to the increasing research activities and the presence of major market players. Additionally, the well-developed healthcare sector is anticipated to boost the immunoprecipitation market in the region.

Europe is expected to hold the second largest position in the global immunoprecipitation market. The market growth in this region is attributed to the availability of funds for research.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the growing investment from governments, growing biotechnology research in these regions, and raising awareness about personalized therapeutics.

On the other hand, the Middle East & Africa is expected to account for the least share of the market.

Segmentation

The global immunoprecipitation market has been segmented into type, product, end-user, and region.

The market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.

The market, by type, has been segmented into kit, reagent, and others.

The market, based on reagent, has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers.

The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.

Key Players

Some of the key players in the global immunoprecipitation market are Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Merck KGaA, BioLegend, Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology, Inc., Geno Technology Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/immunoprecipitation-market-7816 

World Dental Industry Market Estimation Of Top Key Players Shares, Revenue, Analysis And Forecasts Till 2023

 

Market Highlights

The dental industry includes the diagnosis, treatment, instruments, and devices related to oral health. There are various problems related to oral health such as pigmentation in gums, teeth cavity, brown or discoloration of teeth and others which are treated under the dental, medical industry. The key factors driving the dental industry include rising aging population globally, growing demand for cosmetic dentistry treatments, and increasing demand for dental procedures.

However, factors such as low dental insurance coverage compared to general health, lack of technological awareness and grey market of dental products, hinder the market growth. The market for the global dental industry market size is estimated to grow at an approximate CAGR of 7.6% from 2018 to 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7637 

Segmentation

The global dental industry market is segmented on the basis of discipline, consumables and end users. On the basis of the discipline, the market is categorized into restorative dentistry, endodontics, prosthodontics, orthodontics, periodontics, and oral surgery.

On the basis of consumables, the global dental industry market is segmented into dental burs, whitening material, dental biomaterial, gingival retraction material, dental anesthetic, dental syringe, and endodontic supplies. The dental biomaterial segment is sub-segmented into dental cement, dental bone graft and regenerative tissue material. The gingival retraction material is further sub-segmented into gingival hemostatic agents, gingival retraction cord and gingival retraction paste/gels/cap. The dental anesthetic is further sub-segmented into topical anesthetics, injectable anesthetic, and non-injectable anesthetic. The dental syringe is sub-segmented into a non-disposable syringe and disposable syringes/ safety syringes. The endodontic supplies are sub-segmented into files and cement. On the basis of the end-user, the market is segmented into dental hospitals & clinics, dental institutes and dental academic and research institutes.

On a regional basis, the global dental industry market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the global dental industry market owing to the presence of well-established healthcare sector, growing prevalence of dental problems and also high disposable income. Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to the rising awareness about treatment and increasing healthcare facilities provides a favourable scenario for market growth.

Regional Analysis

The Americas dominate the global dental industry market owing to the increasing prevalence of fungal infection in the mouth, growing demand for cosmetic dentistry treatments and a huge patient population suffering from oral diseases across the Americas. According to the Centers for Disease Control and Prevention the US oral and dental health data 84.6% of children aged 2-17 years have a dental visit in the US in 2016 which increase the dental industry in this region.

Moreover, rising healthcare expenditure and the presence of developed economies like the US and Canada fuel the market growth.

Europe is second in the global dental industry market owing to a huge number of children’s suffering oral problems, increasing geriatric population, and presence of the developed economies like the UK, Italy, France, and others.  Asia-Pacific region is the fastest growing market owing to the presence of developing economies, a growing healthcare sector and rising geriatric population drive the market with the region. The Middle East & Africa has the least share in the global dental industry market owing to the presence of poor economies and stringent government policies, especially in the African region.

Key Players

Henry Schein Inc., Hu-Friedy Mfg Co., Ivoclar Vivadent AG, Nakanishi Inc., Patterson Companies Inc., Dentsply Sirona, Ultradent Products Inc., Young Innovations Inc., and 3M Company, Zimmer Biomet, Kangda Medical are some of the major players for global dental industry market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-industry-market-7637